Hennion & Walsh Asset Management’s Ascendis Pharma A/S ASND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-6,312
Closed -$942K 857
2024
Q3
$942K Sell
6,312
-663
-10% -$89.5K 0.04% 463
2024
Q2
$951K Sell
6,975
-59
-0.8% -$8.03K 0.05% 435
2024
Q1
$1.06M Buy
7,034
+882
+14% +$126K 0.06% 406
2023
Q4
$775K Sell
6,152
-86
-1% -$8.57K 0.04% 470
2023
Q3
$584K Buy
6,238
+448
+8% +$41.9K 0.04% 474
2023
Q2
$517K Buy
5,790
+116
+2% +$10.1K 0.03% 499
2023
Q1
$608K Buy
5,674
+964
+20% +$110K 0.04% 464
2022
Q4
$575K Buy
+4,710
New +$547K 0.04% 469
2022
Q2
Sell
-12,351
Closed -$1.45M 758
2022
Q1
$1.45M Sell
12,351
-622
-5% -$72K 0.08% 271
2021
Q4
$1.75M Sell
12,973
-11,545
-47% -$1.72M 0.09% 256
2021
Q3
$3.91M Sell
24,518
-1,155
-4% -$158K 0.21% 134
2021
Q2
$3.38M Buy
25,673
+626
+2% +$83.4K 0.18% 154
2021
Q1
$3.23M Buy
+25,047
New +$3.81M 0.19% 142

Other funds holding ASND

Hennion & Walsh Asset Management's ASND Position: Q4 2024 in Review

Hennion & Walsh Asset Management sold out of Ascendis Pharma A/S (ASND) in Q4 2024, closing a stake of 6,312 shares — an estimated $942K sold.

Hennion & Walsh Asset Management first reported a position in ASND in Q1 2021 and held it in 13 quarters. The position peaked at $3.91M in Q3 2021. 214 funds tracked by Wall St. Rank hold ASND as of Q4 2024.

  • Hennion & Walsh Asset Management reported no remaining Ascendis Pharma A/S position as of Q4 2024 after selling out during the quarter.
  • Hennion & Walsh Asset Management sold 6,312 Ascendis Pharma A/S shares in Q4 2024, an estimated $942K.
  • Hennion & Walsh Asset Management first reported a position in Ascendis Pharma A/S in Q1 2021 and held it in 13 quarters.
  • Hennion & Walsh Asset Management's Ascendis Pharma A/S position peaked at $3.91M in Q3 2021.
  • 214 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q4 2024.

Based on Hennion & Walsh Asset Management's 13F filing for Q4 2024, filed 15 Jan 2025.